RedHill submits MAA for ondansetron
Seeking Alpha - at Seeking Alpha - Tue Dec 09, 11:38AM CST
INSY: 41.00 (+1.82), TSRO: 37.34 (-0.05), HRTX: 9.05 (+0.38), RDHL: 12.98 (+0.80), GWPH: 72.41 (+1.18), OPK: 8.18 (-0.11), GALE: 1.69 (unch)
TESARO and AnaptysBio Expand Immuno-Oncology Collaboration to Include Novel Bispecific Antibody Candidate
GlobeNewswire - Tue Dec 02, 4:14AM CST
--Candidate Will Target Two Undisclosed Immune Checkpoints
TSRO: 37.34 (-0.05)
TESARO to Present at the 2014 Deutsche Bank BioFEST
GlobeNewswire - Tue Nov 25, 4:00PM CST
TESARO, Inc. (Nasdaq:TSRO) announced today that Mary Lynne Hedley, Ph.D., President and COO of TESARO, will present at the 2014 Deutsche Bank BioFEST Conference on Tuesday, December 2, 2014 at 4:00 p.m. ET in Boston.
TSRO: 37.34 (-0.05), DB: 30.78 (-0.56)
TESARO to Present at the Nasdaq 31st Investor Program
GlobeNewswire - Tue Nov 25, 7:07AM CST
TESARO, Inc. (Nasdaq:TSRO) announced today that Lonnie Moulder, CEO of TESARO, will present at the Nasdaq 31 Investor Program on Tuesday, December 2, 2014 at 10:15 a.m. GMT in London.
TSRO: 37.34 (-0.05)
Myriad Genetics, Tesaro Tie Up for myChoice Cancer Test - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 21, 2:10PM CST
New data revealed Myriad's (MYGN) myChoice HRD score as an efficient predictor of niraparib sensitivity in patient-derived xenograft models of ovarian cancer
MYGN: 33.98 (-1.15), TSRO: 37.34 (-0.05), ANIP: 54.28 (+2.33), AFFX: 8.94 (-0.36)
TESARO and Myriad Announce Companion Diagnostics Collaboration
GlobeNewswire - Thu Nov 20, 6:45AM CST
TESARO, Inc. (Nasdaq:TSRO) and Myriad Genetics (Nasdaq:MYGN) today announced a collaboration utilizing Myriad's myChoice HRD companion diagnostic (CDx) to identify tumor tissue with a deficiency in homologous recombination. Under the terms of the agreement, TESARO will utilize Myriad's test to enrich the target population for potential responders to niraparib. Myriad will provide testing services and pursue necessary regulatory approvals in support of TESARO's development of niraparib.
MYGN: 33.98 (-1.15), TSRO: 37.34 (-0.05)
'Fast Money' Recap: Was Friday the Start of a Bull Rally in Gold?
at The Street - Sat Nov 15, 4:00AM CST
The trading panel took a look at gold prices, which climbed 2.3% on Friday, as well as the potential for a pullback in biotech stocks.
AMZN: 307.32 (-0.04), TSRO: 37.34 (-0.05), XBI: 183.73 (-0.31), IBB: 306.10 (-3.95), CELG: 114.49 (-2.25), GILD: 104.13 (-0.18), GLD: 117.41 (-0.28), MCD: 90.62 (-0.35), SLV: 16.30 (-0.03), GDX: 18.65 (-0.35), TWTR: 37.10 (+0.40), AAPL: 109.73 (-1.89), BABA: 105.11 (+0.14)
After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 4:38PM CST
HK: 2.01 (-0.09), NTES: 99.45 (-1.33), CIG: 4.90 (+0.03), TSRO: 37.34 (-0.05), DDD: 30.00 (-0.59), CLDX: 18.03 (-0.16), SCMP: 13.93 (-0.13), BVN: 9.65 (-0.19), ABGB: 12.37 (-0.24), SSE: 4.58 (-0.12)
TESARO to Present at the Jefferies 2014 Global Healthcare Conference
GlobeNewswire - Wed Nov 12, 7:00AM CST
TESARO, Inc. (Nasdaq:TSRO) announced today that Lonnie Moulder, CEO of TESARO, will present at the Jefferies 2014 Global Healthcare Conference on Wednesday, November 19, 2014 at 11:20 a.m. GMT in London.
TSRO: 37.34 (-0.05)
TESARO's (TSRO) CEO Lonnie Moulder on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Nov 07, 1:31AM CST
TSRO: 37.34 (-0.05)
Tesaro beats 3Q profit forecasts
Automated Insights - Thu Nov 06, 4:04AM CST
WALTHAM, Mass. (AP) _ Tesaro Inc. (TSRO) on Thursday reported a third-quarter loss of $36.2 million.
TSRO: 37.34 (-0.05)
Tesaro beats by $0.03
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 4:07PM CST
TSRO: 37.34 (-0.05)
TESARO Announces Third-Quarter 2014 Operating Results
GlobeNewswire - Wed Nov 05, 3:36PM CST
-- Oral Rolapitant New Drug Application (NDA) Accepted for Review by U.S. FDA
TSRO: 37.34 (-0.05)
Tesaro reports November 5
Seeking Alpha - at Seeking Alpha - Wed Oct 22, 4:34PM CDT
TSRO: 37.34 (-0.05)
Tesaro to Announce Third-Quarter 2014 Financial Results on November 5, 2014
GlobeNewswire - Wed Oct 22, 3:01PM CDT
TESARO, Inc. (Nasdaq:TSRO) will announce its third-quarter 2014 financial results on Wednesday, November 5, 2014, after the close of the U.S. financial markets. TESARO's senior management team will host a conference call and live audio webcast at 4:15 p.m. ET on November 5, 2014 to discuss the Company's results in greater detail.
TSRO: 37.34 (-0.05)
TESARO Announces Closing of $201.25 Million Public Offering of 3.00% Convertible Senior Notes Due 2021, Including Full Exercise of the Underwriters' Option to Purchase Additional Notes
GlobeNewswire - Mon Sep 29, 3:01PM CDT
TESARO, Inc. (Nasdaq:TSRO) announced today the closing of its previously announced underwritten public offering of $201.25 million aggregate principal amount of its 3.00% convertible senior notes due 2021 (the "notes"
TSRO: 37.34 (-0.05), DB: 30.78 (-0.56)
Weakness Seen in Tesaro, Inc. (TSRO): Stock Tumbles 9.0% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Sep 24, 7:54AM CDT
Make sure to keep a close watch on Tesaro in the near future, and especially on earnings estimates following the recent slump.
TSRO: 37.34 (-0.05)
TESARO Announces Pricing of $175 Million of 3.00% Convertible Senior Notes Due 2021
GlobeNewswire - Tue Sep 23, 9:40PM CDT
TESARO, Inc. (Nasdaq:TSRO) announced today the pricing of $175 million aggregate principal amount of its 3.00% convertible senior notes due 2021 (the "notes"
TSRO: 37.34 (-0.05), DB: 30.78 (-0.56)
Nasdaq stocks posting largest percentage decreases
AP - Tue Sep 23, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
UBNT: 29.93 (+0.48), TSRO: 37.34 (-0.05), WATT: 7.25 (-0.22), MLAB: 71.38 (-3.20), NVC.TO: 7.15 (+0.08), NVCN: 6.18 (unch), PBSK: 14.99 (+0.01)
TESARO Announces Offering of $165 Million of Convertible Senior Notes Due 2021
GlobeNewswire - Mon Sep 22, 3:46PM CDT
TESARO, Inc. (Nasdaq:TSRO) announced today that, subject to market and other conditions, it intends to offer $165 million aggregate principal amount of convertible senior notes due 2021 (the "notes"
TSRO: 37.34 (-0.05), DB: 30.78 (-0.56)